1. Home
  2. RZLT vs CURR Comparison

RZLT vs CURR Comparison

Compare RZLT & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$2.35

Market Cap

187.3M

Sector

Health Care

ML Signal

HOLD

Logo Currenc Group Inc. Ordinary Shares

CURR

Currenc Group Inc. Ordinary Shares

HOLD

Current Price

$1.73

Market Cap

224.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RZLT
CURR
Founded
2010
2013
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
187.3M
224.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RZLT
CURR
Price
$2.35
$1.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$10.33
$3.50
AVG Volume (30 Days)
15.9M
255.9K
Earning Date
02-11-2026
11-01-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$40,227,053.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$14.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.07
$0.33
52 Week High
$11.46
$7.08

Technical Indicators

Market Signals
Indicator
RZLT
CURR
Relative Strength Index (RSI) 34.56 38.70
Support Level $1.87 $1.61
Resistance Level $2.43 $2.03
Average True Range (ATR) 0.29 0.16
MACD 0.21 0.01
Stochastic Oscillator 56.73 22.73

Price Performance

Historical Comparison
RZLT
CURR

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.

Share on Social Networks: